Regeneron Pharmaceuticals, Inc. vs Elevance Health, Inc.
μκ°μ λ°λ₯Έ μκ°μ΄μ‘ λΉκ΅
Regeneron Pharmaceuticals, Inc.
$81.5B
μμ #193
Elevance Health, Inc.
$84.6B
μμ #188
μκ°μ λ°λ₯Έ μκ°μ΄μ‘
μ£Όμ μκ°
- Regeneron Pharmaceuticals, Inc.μ΄(κ°) 2012λ κΉμ§ Elevance Health, Inc.μ(λ₯Ό) μΆμνμ΅λλ€
- Elevance Health, Inc.μ΄(κ°) 2017λ κΉμ§ Regeneron Pharmaceuticals, Inc.μ(λ₯Ό) μΆμνμ΅λλ€
- Regeneron Pharmaceuticals, Inc.μ΄(κ°) 2025λ κΉμ§ Elevance Health, Inc.μ(λ₯Ό) μΆμνμ΅λλ€
- Elevance Health, Inc.μ΄(κ°) 2026λ κΉμ§ Regeneron Pharmaceuticals, Inc.μ(λ₯Ό) μΆμνμ΅λλ€
μ°λλ³ λΉκ΅
| μ°λ | Regeneron Pharmaceuticals, Inc. | Elevance Health, Inc. | μ λ |
|---|---|---|---|
| 2026 | $81.5B | $84.6B | Elevance Health, Inc. |
| 2025 | $79.3B | $75.0B | Regeneron Pharmaceuticals, Inc. |
| 2024 | $72.8B | $77.5B | Elevance Health, Inc. |
| 2023 | $89.7B | $97.8B | Elevance Health, Inc. |
| 2022 | $73.7B | $105.1B | Elevance Health, Inc. |
| 2021 | $64.5B | $94.0B | Elevance Health, Inc. |
| 2020 | $49.4B | $64.3B | Elevance Health, Inc. |
| 2019 | $38.4B | $59.7B | Elevance Health, Inc. |
| 2018 | $38.2B | $51.3B | Elevance Health, Inc. |
| 2017 | $38.4B | $43.4B | Elevance Health, Inc. |
| 2016 | $37.5B | $27.3B | Regeneron Pharmaceuticals, Inc. |
| 2015 | $55.5B | $26.0B | Regeneron Pharmaceuticals, Inc. |
| 2014 | $41.9B | $23.0B | Regeneron Pharmaceuticals, Inc. |
| 2013 | $28.1B | $16.7B | Regeneron Pharmaceuticals, Inc. |
| 2012 | $17.5B | $10.8B | Regeneron Pharmaceuticals, Inc. |
| 2011 | $5.7B | $11.5B | Elevance Health, Inc. |
| 2010 | $3.4B | $9.8B | Elevance Health, Inc. |
| 2009 | $2.5B | $10.0B | Elevance Health, Inc. |
| 2008 | $1.9B | $7.2B | Elevance Health, Inc. |
| 2007 | $2.5B | $15.1B | Elevance Health, Inc. |
| 2006 | $2.1B | $13.5B | Elevance Health, Inc. |
| 2005 | $1.6B | $13.7B | Elevance Health, Inc. |
| 2004 | $941.1M | $9.9B | Elevance Health, Inc. |
| 2003 | $1.5B | $6.4B | Elevance Health, Inc. |
| 2002 | $1.9B | $5.4B | Elevance Health, Inc. |
| 2001 | $2.9B | $4.3B | Elevance Health, Inc. |